«

»

Pharma R&D return on investment at highest level in 8 years

The return on investment for pharmaceutical research and development has risen to its highest level since 2014, according to Deloitte's 12th annual pharmaceutical innovation report.

Read the full post at Becker's Hospital Review - Healthcare News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive